FindTrial
Sign In

A clinical trial to study the route of enteral feeding (nasogastric versus nasojejunal) in acute pancreatitis

Role of enteral nutrition in preventing complications in severe acute pancreatitis in randomised control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2009/091/000948
Enrollment
100
Registered
2009-12-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: enteral feeding: nasogastric Control Intervention1: enteral feeding: nasojejunal

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria 1. Patients with SAP is defined as acute abdominal pain requiring admission to hospital and associated with Raised serum amylase >3 time upper normal limit US or CT evidence of SAP 2. Only patients with SAP will be included as defined by APACHE II score > 8 CT score > 6 Presence of organ failure as defined by a) Shock: SBP< 90mmHg b) Pulmonary insufficiency: PaO2 <60mmHg c) Renal failure: serum creatinine 2mg/dl d) Gastrointestinal bleeding > 500ml/24hr

Exclusion criteria

Exclusion criteria: a) A delay between onset of pain and presentation to the hospital of more than 4 week b) Patient already on oral feeds at the time of presentation c) Patients undergoing surgery before the completion of 7 days of refeeding schedule.

Design outcomes

Primary

MeasureTime frame
 Clinical outcome would include clinical infectionsTimepoint: weekly during hospitalisation—

Secondary

MeasureTime frame
C-reactive proteins, prealbumin,endoxoxemia,hospital stayTimepoint: baseline and after one week of intervention—

Countries

India

Contacts

Public ContactDr Anoop Saraya
ansaraya@yahoo.com011-26593294

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026